Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2017-02-23 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2016 annual report - ENG.pdf
Annual Report Classification · 100% confidence The document is explicitly titled '2016 ANNUAL REPORT' and contains comprehensive sections including a letter to stakeholders, management report, consolidated financial statements, notes to financial statements, and auditor's report. It covers the full fiscal year 2016 and provides detailed financial performance data, business reviews, and strategic outlooks. It is clearly the primary annual report of the company, not an announcement or a summary. FY 2016
2017-02-23 English
UCB_RA_2016_FR.pdf
Annual Report Classification · 100% confidence The document is titled '2016 RAPPORT ANNUEL' (2016 Annual Report) and contains comprehensive financial data, including consolidated financial statements, management reports, and auditor reports. It is a full-length annual report, not an announcement or a summary, and therefore fits the definition of an Annual Report (10-K). FY 2016
2017-02-23 French
UCB_RA_2016_NL.pdf
Annual Report Classification · 100% confidence The document is titled '2016 JAARVERSLAG' (2016 Annual Report) and contains comprehensive financial information, including a letter to stakeholders, management reports, consolidated financial statements, and auditor reports. It covers the full fiscal year 2016 and provides detailed business performance metrics, making it a standard Annual Report. FY 2016
2017-02-23 Dutch
20170216 - Transparency notification BlackRock Inc.pdf
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'transparency notification' received pursuant to Article 14 of the law of 2 May 2007 regarding the disclosure of large shareholdings. It details the change in BlackRock, Inc.'s shareholding in UCB SA/NV, crossing the 3% threshold. This type of filing, which reports changes in significant ownership stakes, directly corresponds to the definition of a Major Shareholding Notification (MRQ). The document is a formal regulatory disclosure, not a general announcement of a report (RPA) or a miscellaneous filing (RNS).
2017-02-16 English
20170216 - Notification de transparence BlackRock Inc.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de transparence" (Transparency Declaration) and explicitly states it is a notification received by UCB SA from BlackRock, Inc., regarding an acquisition of voting shares that caused BlackRock to cross the 3% ownership threshold on February 10, 2017. This content directly corresponds to regulatory requirements for reporting changes in significant share ownership. The filing category that matches this description is Major Shareholding Notification (MRQ). The document is a formal notification detailing the change in holdings, not a general regulatory announcement (RNS) or a report publication announcement (RPA), as it contains the substantive data itself.
2017-02-16 French
20170216 - Transparantieverklaring BlackRock Inc.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and explicitly states it is issued based on Article 14 of the law regarding the disclosure of major shareholdings ('openbaarmaking van belangrijke deelnemingen'). It details that BlackRock, Inc. has increased its stake in UCB NV, crossing the 3% threshold on February 10, 2017. This content directly corresponds to notifications about changes in significant share ownership levels, which matches the definition for Major Shareholding Notification (MRQ). Although it is a formal regulatory disclosure, MRQ is more specific than the general 'RNS' fallback.
2017-02-16 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.